Age-associated changes of the intestinal epithelial barrier: Local and systemic implications

Expert Review of Gastroenterology and Hepatology

Volumn 9, Issue 12, 2015, Pages 1467-1469

  Nicoletti, Claudio ^a  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

Author keywords

Ageing; Infection; Inflammageing; Intestinal permeability; Intestine; Microbiota

Indexed keywords

CLAUDIN 2; FLAGELLIN; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; PREBIOTIC AGENT; PROBIOTIC AGENT; SYMPBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGING; ANDROPAUSE; ANXIETY; BEHAVIOR; CELIAC DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; COGNITION; COLORECTAL CANCER; CYTOKINE PRODUCTION; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DIET; DISEASE ASSOCIATION; DYSBIOSIS; EDITORIAL; ENVIRONMENTAL FACTOR; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL TRACT; HEART FAILURE; HOST PATHOGEN INTERACTION; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINAL EPITHELIAL BARRIER; INTESTINE MUCOSA PERMEABILITY; LONGEVITY; MENOPAUSE; MICROFLORA; NONHUMAN; OBESITY; PERMEABILITY BARRIER; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; TH17 CELL; AGE; AGED; ANIMAL; IMMUNOLOGY; INTESTINE FLORA; INTESTINE MUCOSA; METABOLISM; MUCOSAL IMMUNITY; PERMEABILITY; PHYSIOLOGY;

AGE FACTORS; AGED; AGING; ANIMALS; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INTERLEUKIN-6; INTESTINAL MUCOSA; LONGEVITY; PERMEABILITY; QUALITY OF LIFE;

EID: 84945217392     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/17474124.2015.1092872     Document Type: Editorial

References (21)

1. Man AL, Bertelli E, Rentini S, et al. Age-associated modifications of intestinal permeability and innate immunity in human small intestine. Clin Sci (Lond) 2015;129:515-27
2. Van Itallie CM, Holmes J, Bridges A, et al. The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J Cell Sci 2008;121:298-305
3. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000;51:245-70
4. Gomez CR, Karavitis J, Palmer JL, et al. Interleukin-6 contributes to age-related alteration of cytokine production by macrophages. Mediators Inflamm 2010;2010:475139
5. Kimura A, Kishimoto T. IL-6: regulator of Treg/TH17 balance. Eur J Immunol 2010;40:1830-5
6. Schmitt V, Rink L, Uciechowski P. The Th17/Treg balance is disturbed during aging. Exp Gerontol 2013;48:1379-86
7. Rera M, Clark RI, Walker DW. Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. Proc Natl Acad Sci USA 2012;109:21528-33
8. Clairembault T, Leclair-Visonneau L, Coron E, et al. Structural alterations of the intestinal epithelial barrier in Parkinson’s disease. Acta Neuropathol Commun 2015;3:12-18
9. Yacyshyn B, Meddings J, Sadowski D, et al. Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability. Dig Dis Sci 1996;41:2493-8
10. Suzman R, Beard JR, Boerma TS, Chatterji S. Health in an ageing world— what do we know? Lancet 2015;385:484-6
11. Libina N, Berman JR, Kenyon C. Tissue-specific activities of C. elegans DAF-1 in the regulation of lifespan. Cell 2003;115:489-502
12. Rera M, Azizi MJ, Walker DW. Organ-specific mediation of lifespan extension: more than a gut feeling? Ageing Res Rev 2013;12:436-44
13. Kenyon CJ. The genetics of ageing. Nature 2010;464:504-12
14. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012;488:178-84
15. Rossen NG, MacDonald JK, de Vries EM, et al. Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review. World J Gastroenterol 2015;21:5359-71
16. Petrof EO, Gloor GB, Vanner SJ, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome 2013;1:3-8
17. Zhang S. Faeces-filled pill stops gut infection. Nature 2013
18. Maes M, Kubera M, Leunis JC, et al. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr Scand 2013;127:344-54
19. Bischoff SC, Barbara G, Buurman W, et al. Intestinal permeability-a target for disease prevention and therapy. BMC Gastroenterol 2014;14:189
20. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behaviour and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011;23:255-64
21. Park AJ, Collins J, Blennerhassett PA, et al. Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol Motil 2013;25:733-e575